This study evaluates how demographic factors and comorbid conditions impact the prognosis and treatment of patients with laryngeal squamous cell cancer (LSCC) based on medical records from 2008 to 2019.
A total of 573 patients were analyzed, revealing that the majority were men and smokers, with significant survival rates indicating better outcomes for early-stage LSCC treated with endolaryngeal laser surgery (ELS) compared to radiotherapy.
It was concluded that ELS offers superior overall and disease-free survival rates for early-stage LSCC, while advanced cases showed better outcomes with total laryngectomy compared to chemoradiotherapy; recurrence risk was notably higher in certain categories of tumors.*